| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0058 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |